Literature DB >> 6475950

Iga nephropathy: presentation, clinical course, and prognosis in children and adults.

R J Wyatt, B A Julian, D B Bhathena, B L Mitchell, N H Holland, H H Malluche.   

Abstract

Eighty-two patients, 56 male and 26 female, biopsied since 1972 had IgA nephropathy. At the time of kidney biopsy, 24 patients were children and 58 were adults. In both groups the clinical course was documented in sufficient detail to allow prediction of disease outcome. Twenty-six (45%) of the adult patients had chronic renal insufficiency either at first evaluation or subsequently. Fourteen eventually required chronic hemodialysis. Hypertension as the initial sign of disease was seen more frequently in patients with chronic renal insufficiency. Adult males were more likely to have chronic renal insufficiency. The life table method was used to predict age at initiation of dialysis and kidney survival from date of onset of clinically apparent disease. Thirty-five percent of the male patients were predicted to require dialysis by age 40. Kidney death was predicted at 10 years from onset for 33% of male and 22% of all patients biopsied as adults. While all patients with progressive disease had over 2.0 g/24 h urinary protein excretion at least once, many individuals with serum creatinine concentration below 1.5 mg/dL showed marked fluctuation in degree of proteinuria, often exceeding 2.0 g/24 h. Thus, in some cases, degree of proteinuria was not a reliable predictor of outcome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475950     DOI: 10.1016/s0272-6386(84)80071-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  21 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Quantitative analysis of glomeruli lesions in patients with mesangial proliferative glomerulonephritis.

Authors:  J Sun; Y Wang
Journal:  J Tongji Med Univ       Date:  1996

Review 3.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

4.  A clinicopathological comparison between IgA nephropathy and Henoch-Schönlein purpura nephritis in children: use of the Oxford classification.

Authors:  Xueqian Li; Mengmeng Tang; Xingfeng Yao; Nan Zhang; Jianfeng Fan; Nan Zhou; Qiang Sun; Zhi Chen; Qun Meng; Lei Lei; Hejia Zhang; Chen Ling; Lin Hua; Xiangmei Chen; Xiaorong Liu
Journal:  Clin Exp Nephrol       Date:  2019-08-29       Impact factor: 2.801

5.  Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy.

Authors:  R J Hogg; D A Savino
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

6.  Treatment of severe IgA nephropathy in children.

Authors:  S P Andreoli; J M Bergstein
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy.

Authors:  Dan Wu; Xueqian Li; Xingfeng Yao; Nan Zhang; Lei Lei; Hejia Zhang; Mengmeng Tang; Jie Ni; Chen Ling; Zhi Chen; Xiangmei Chen; Xiaorong Liu
Journal:  Clin Exp Nephrol       Date:  2021-02-23       Impact factor: 2.801

8.  Regionalization in hereditary IgA nephropathy.

Authors:  R J Wyatt; M L Rivas; B A Julian; P A Quiggins; S Y Woodford; R G McMorrow; R W Baehler
Journal:  Am J Hum Genet       Date:  1987-07       Impact factor: 11.025

9.  IgA nephropathy in a child with human immunodeficiency virus type 1 infection.

Authors:  H Trachtman; B Gauthier; A Vinograd; E Valderrama
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

10.  Prognostication in children with renal disease--with emphasis on IgA nephropathy.

Authors:  R J Hogg; R Browne
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.